St. Paul’s Eye Unit is based within the Royal Liverpool University Hospital and is associated with the University of Liverpool. There are currently sixteen substantive consultants plus two clinical academics at consultant level. There are two locum consultants in post. There are two clinical lecturers, three associate specialists, a specialty doctor, twelve specialist trainees and eight sub-specialty fellows.
Applications are invited for this post which is aimed at experienced ophthalmologists who may or may not be looking to continue to achieve the competencies required to obtain CCT. This not recognised as a training post. The start date will be April 2026. Duration of the post is twelve months in the first instance. It is likely that the post will be extended if mutually agreed. There are opportunities to engage in research and to benefit from the many sub-specialist training opportunities available in this centre of excellence.
The objective of this post is to significantly improve the trainee’s ability to diagnose, treat and monitor adult ocular tumours and to provide adequate counselling and support.
Patients are first examined by a Ocular Oncology Fellow before being seen by the Consultant Ocular Oncologist.
Treatments for intraocular melanoma include: ruthenium plaque radiotherapy, proton beam radiotherapy, trans-pupillary thermotherapy, trans-scleral local resection, trans-retinal endoresection, and, of course, enucleation and photodynamic therapy. Conjunctival tumours are treated by local excision followed by brachytherapy and/or topical chemotherapy.
Trainees in ocular oncology will first assist in surgical procedures, before performing surgery under supervision and eventually unsupervised, according to their individual aptitudes and requirements.
Follow-up assessments are performed each Thursday and Friday, with these clinics attended by 30-40 patients each week.
Multidisciplinary meetings are held every Monday and occasionally with ophthalmic pathologists.
The post offers good opportunities for clinical and basic science research. Special arrangements can be made for the Ocular Oncology Fellow to receive training and to maintain skills in general ophthalmology
Liverpool University Hospitals NHS Foundation Trust comprises Aintree University Hospital, Broadgreen Hospital & Royal Liverpool University Hospital.
We are part of NHS University Hospitals of Liverpool Group, formed on 1 Nov 2024 from the coming together of LUHFT and Liverpool Women’s NHS Foundation Trust. The Group was born from a shared aim to improve the care we provide our patients.
UHLG is one of the largest employers in the region, with over 16,800 colleagues dedicated to caring for our communities - from birth and beyond.
For the 630,000 people across Merseyside, we are their local NHS. We provide general and emergency hospital care, alongside highly specialised regional services for more than two million people in the North West.
Aintree University Hospital is the single receiving site for adult major trauma patients in Cheshire and Merseyside and hosts a number of regional services including an award-winning stroke facility. Broadgreen Hospital is home to elective surgical, diagnostic and treatment services, together with specialist patient rehabilitation. Liverpool Women’s Hospital specialises in the health of women and babies, delivering over 7,200 babies in the UK’s largest single site maternity hospital each year. The Royal Liverpool University Hospital is the largest hospital in the country to provide inpatients with 100% single bedrooms and focuses on complex planned care and specialist services.
For roles at Liverpool Women’s, visit their careers page .
New patients are seen on Mondays. All are first examined by a Specialist Trainee or Ocular Oncology Fellow before being seen by the Consultant Ocular Oncologist.
Responsible for Ward rounds following Treatments for intraocular melanoma include: ruthenium and iodine plaque radiotherapy, proton beam radiotherapy, trans-pupillary thermotherapy, trans-scleral local resection, trans-retinal
endoresection, and, of course, enucleation. Choroidal haemangiomas are treated with photodynamic therapy.
Conjunctival tumours are treated by local excision followed by brachytherapy and/or topical chemotherapy. One operating theatre with anaesthetist is available for ocular oncology each Tuesday morning and Tuesday afternoon. In addition, two operating theatres and one anaesthetist are available for ocular oncology each Friday morning.
Report job
